HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Do we still need to study palonosetron for chemotherapy-induced nausea and vomiting? A cumulative meta-analysis.

AbstractINTRODUCTION:
The aim is to conduct an updated systematic review comparing palonosetron to other 5-HT3RAs for the prophylaxis of CINV, assess for publication biases, and determine whether further RCTs are required, that could potentially lead to a different meta-conclusion.
METHODS:
Random-effects analysis model was used to generate odds ratio (OR), risk differences (RD) and accompanying 95% confidence intervals (CI). Funnel plots to assess for biases and cumulative meta-analyses to assess effect size over time were generated.
RESULTS:
4145 patients were randomized to palonosetron and 4911 received other 5-HT3RAs. In the majority of efficacy endpoints, the meta-conclusion has not changed over time - recent clinical trials simply narrow CIs the meta-conclusion. Safety profile boasts a stable conclusion over time. No publication biases exist.
CONCLUSION:
Considering the vast amount of resources needed to conduct RCTs, resources should be dedicated to other prophylactic treatments/settings which have not been as well explored.
AuthorsRonald Chow, Matti Aapro, Rudolph M Navari, Richard Gralla, Nicholas Chiu, Leonard Chiu, Stephanie Chan, Marko Popovic, Henry Lam, Michael Lock, Carlo DeAngelis
JournalCritical reviews in oncology/hematology (Crit Rev Oncol Hematol) Vol. 142 Pg. 164-186 (Oct 2019) ISSN: 1879-0461 [Electronic] Netherlands
PMID31419719 (Publication Type: Comparative Study, Journal Article, Meta-Analysis)
CopyrightCopyright © 2019. Published by Elsevier B.V.
Chemical References
  • Antiemetics
  • Antineoplastic Agents
  • Serotonin 5-HT3 Receptor Antagonists
  • Palonosetron
Topics
  • Antiemetics (therapeutic use)
  • Antineoplastic Agents (adverse effects, therapeutic use)
  • Humans
  • Nausea (chemically induced, prevention & control)
  • Neoplasms (drug therapy)
  • Odds Ratio
  • Palonosetron (therapeutic use)
  • Serotonin 5-HT3 Receptor Antagonists (therapeutic use)
  • Vomiting (chemically induced, prevention & control)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: